Bortezomib
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | ||
| - | Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.[2] This includes multiple myeloma in those who have and have not previously received treatment.[3] It is generally used together with other medications.[3] | + | Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.<ref name="a2">[https://www.drugs.com/monograph/bortezomib.html "Bortezomib Monograph for Professionals".] Drugs.com. Retrieved 13 October 2019.</ref>[2] This includes multiple myeloma in those who have and have not previously received treatment.[3] It is generally used together with other medications.[3] |
[[2f16]]. | [[2f16]]. | ||
Revision as of 12:49, 15 January 2024
| |||||||||||
References
- ↑ "Bortezomib Monograph for Professionals". Drugs.com. Retrieved 13 October 2019.
